April 21 () - AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met ‌the main goal of a late-stage trial ...

AstraZeneca announced in May 2026 that its drug Ultomiris significantly reduced urine protein levels in patients with IgA ...

AstraZeneca's CEO told ⁠daily ⁠Handelsblatt on Tuesday that Germany ⁠risks missing out on new drugs that the ​Anglo-Swedish ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...

A global drug company which pioneered the Covid vaccine has been victim of a cyber attack, Metro can reveal. AstraZeneca was ...

The Industrial Estate Authority of Thailand (IEAT) and AstraZeneca (Thailand) Co., Ltd. are moving forward with the Health ...

AstraZeneca (AZN) tozorakimab achieves primary endpoint in Phase III MIRANDA trial, reducing COPD exacerbations in smokers ...

View AstraZeneca PLC AZN stock quote prices, financial information, real-time forecasts, and company news from CNN.

Wondering if AstraZeneca at £152.30 is still offering value after a strong run, or if most of the easy gains are already ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Astrazeneca (AZN) is a stock that can certainly grab the attention of many investors ...